SANUWAVE Health, Inc announced it has entered into a Securities Purchase Agreement and has issued convertible Promissory Notes in aggregate principal amount of $1,800,000, first warrants to purchase an additional 32,500,000 shares of common stock of the Company with an exercise price of $0.067 per share and warrants to purchase an additional 32,500,000 shares of common stock of the Company with an exercise price of $0.04 per share for aggregate proceeds of $1,800,000 on June 18, 2024